USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14181056

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of Basic Prolin-rich Lacrimal protein (BPLP) gene products, such as Opiorphin, for establishing a prognosis, a diagnosis or the monitoring of a pathological state or of treatment efficacy in a subject and the related method of use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT PASTEUR75724 PARIS CEDEX 15

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dufour, Evelyne Vanves, FR 6 12
Jouannet, Pierre Paris, FR 2 0
ROUGEOT, Catherine Chevreuse, FR 28 129
Ungeheuer, Marie-Noelle Maurepas, FR 8 12
Villard-Saussine, Sylvie Issy-Les-Moulineaux, FR 9 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation